Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.8M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
9.54M
-
Shares change
-
-85.5K
-
Total reported value, excl. options
-
$32.7M
-
Value change
-
-$394K
-
Number of buys
-
19
-
Number of sells
-
-21
-
Price
-
$3.43
Significant Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q4 2018
66 filings reported holding NAGE - Niagen Bioscience, Inc. - Common Stock as of Q4 2018.
Niagen Bioscience, Inc. - Common Stock (NAGE) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.54M shares
of 79.8M outstanding shares and own 11.96% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.91M shares), ICONIQ Capital, LLC (1.71M shares), Vanguard Group Inc (1.59M shares), Tieton Capital Management, LLC (1.09M shares), STATE STREET CORP (555K shares), NORTHERN TRUST CORP (411K shares), GEODE CAPITAL MANAGEMENT, LLC (347K shares), FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. (268K shares), UBS Group AG (152K shares), and Bank of New York Mellon Corp (129K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.